Systemic Administration of Heparin Ameliorates Radiation-induced Oral Mucositis-preclinical Studies in Mice
Overview
Affiliations
Purpose: The present study investigates the impact of systemic application of heparins on the manifestation of radiation-induced oral mucositis in a well-established mouse model.
Materials And Methods: Male C3H/Neu mice were irradiated with either single-dose or fractionated irradiation protocols with 5 × 3 Gy/week, given over one (days 0-4) or two (days 0-4, 7-11) weeks. All fractionation protocols were concluded by a local test irradiation (day 7/14) using graded doses to generate complete dose-effect curves. Daily doses of unfractionated or low molecular weight heparin (40 or 200 I.U./mouse, respectively) were applied subcutaneously over varying time intervals. The incidence and the time course of mucosal ulceration, corresponding to confluent mucositis in patients (RTOG/EORTC grade 3), were analysed as clinically relevant endpoints.
Results: Systemic application of heparins significantly increased the iso-effective doses for the induction of mucosal ulceration, particularly in combination with fractionated irradiation protocols. Moreover, a tentative prolongation of the latent time and a pronounced reduction of the ulcer duration were observed.
Conclusion: These data provide the first evidence for a protective and/or mitigative effect of heparins for radiation-induced oral mucositis. Further studies are ongoing investigating the underlying mechanism.
Miura T, Kawano M, Takahashi K, Yuasa N, Habu M, Kimura F Adv Radiat Oncol. 2022; 7(3):100900.
PMID: 35295873 PMC: 8918722. DOI: 10.1016/j.adro.2022.100900.
Homa-Mlak I, Brzozowska A, Mlak R, Szudy-Szczyrek A, Malecka-Massalska T J Clin Med. 2021; 10(19).
PMID: 34640462 PMC: 8509431. DOI: 10.3390/jcm10194444.
Kowaliuk M, Schroder I, Kuess P, Dorr W Strahlenther Onkol. 2019; 195(6):534-543.
PMID: 30689028 PMC: 6531413. DOI: 10.1007/s00066-018-01423-4.